Leerink Partners
An Equity Research Associate in the Rare Diseases field will collaborate with senior analysts to produce research reports evaluating the clinical and commercial prospects of biotechnology therapies. This role requires synthesizing complex biological data with financial analysis to formulate investment recommendations for institutional clients. The position involves building financial models, interviewing industry experts, and maintaining rigorous writing standards for market distribution.
Headquarters
Boston, Massachusetts, United States
Company Size
201-500 employees
Founded
1995
Leerink Partners is an investment bank uniquely dedicated to serving innovation-driven and growth-minded healthcare companies.
Leerink Partners Adds Timothy Michel to Trading and Execution Team
Nov 18, 2025
Leerink questions whether BioNTech can thrive without their 'founders' insight' as stock drops
3 days ago
Leerink Partners reiterates Ardelyx stock rating on pipeline progress
21 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Leerink Partners.
17% above the average for this role
He was on the brink amid SVB’s collapse. Now, Jeff Leerink’s firm leads the pack in health care deals.
2 weeks ago
Scientist, Rare Disease Biology
Amgen
Equity Research Associate Analyst - Biotechnology
Mizuho Financial
Equity Research Associate
Piper Sandler & Co.
Senior Lecturer in Medical Science – Biotechnology
Western Sydney University
Analyst/ Associate - Equity Research, Biotech
Bank of America
Associate, Equity Research – Biotechnology
BTIG